Cucurbitacin IIa
Product Specifications
UNSPSC Description
Cucurbitacin IIa is a triterpene isolated from Hemsleya amalils Diels, induces apoptosis of cancer cells, reduces expression of survivin, reduces phospho-Histone H3 and increases cleaved PARP in cancer cells[1].
Target Antigen
Apoptosis; Survivin
Type
Natural Products
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cucurbitacin-iia.html
Purity
98.46
Solubility
DMSO : 25 mg/mL (ultrasonic;warming;heat to 60°C)
Smiles
C[C@@]([C@@](CC=C1[C@@]2([H])C[C@H](O)[C@@H](O)C1(C)C)([H])[C@@]2(C)C3=O)(C[C@@H](O)[C@]4([H])[C@@](C)(O)C(CCC(C)(C)OC(C)=O)=O)[C@@]4(C3)C
Molecular Weight
562.73
References & Citations
[1]Boykin C, et al. Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation. Br J Cancer. 2011 Mar 1;104(5):781-9.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-N1988/Cucurbitacin-IIa-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-N1988/Cucurbitacin-IIa-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
58546-34-2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
CSB-YP890933HU-01 20 µg
Recombinant Human E3 ubiquitin-protein ligase ZNRF3 (ZNRF3), partial
Ask
View Details CSB-YP890933HU-02 100 µg
Recombinant Human E3 ubiquitin-protein ligase ZNRF3 (ZNRF3), partial
Ask
View Details CSB-YP890933HU-03 1 mg
Recombinant Human E3 ubiquitin-protein ligase ZNRF3 (ZNRF3), partial
Ask
View Details